AI and Patents, are we ready?

It didn’t seem that long ago that people were talking about Artificial intelligence or AI, as something futuristic, or another generation away. Not anymore. AI is rapidly infiltrating many aspects of our lives with automated assistants, smart devices, driverless cars, toys, and more.
While there are seemingly limitless benefits of AI, there is high-level concern about AI’s impact on people and jobs. Research group Gartner predicted that by as early as next year more than 3 million workers globally will be supervised by a “robo-boss.” There is no denial that this technology is creating such unprecedented disruption that governments, companies and […]

December 12th, 2017|

Three honours in one month!

September is proving to be another great month for CreateIP with not one, but three new accolades for IP excellence to add to the trophy shelf.
The first surprise was learning that, for the fifth consecutive year, we have again made it to the finals of the highly prestigious NZ Law Awards in the Intellectual Property Specialist Law Firm of the Year category.

The second was finding out that we achieved top rankings for both Patent Prosecution and Patent Contentious categories in the Asia IP 2017 Patent Survey! Only 10 New Zealand firms can secure this top 10 ranking.

Finally, Rachel Colley will feature […]

September 22nd, 2017|

IP takeaways from BIO 2017

The world of unknowns and patent best practice
Shayne and I recently attended the hugely popular BIO 2017 convention in San Diego, where over 16,000 attendees associated with the life sciences industry share their ideas and innovations.

Besides the social side of the conference (which included entering a 5k charity fun run dressed as a kiwi!), BIO was a great chance for us to re-connect with all the overseas IP professionals we work with, and to make new contacts.

One of the nice things about being a patent attorney is that we all speak a similar global ‘IP language’ albeit with country specific […]

July 5th, 2017|

CreateIP earns respected IAM and WIPR recognitions

We’re pleased to announce that CreateIP partners, Robert Snoep and Rachel Colley, have been recognised as amongst the world’s leading IP professionals 2017 in two of the world’s leading IP guides – the IAM Patent 1000 and WIPR Leaders.
CreateIP founder, Robert Snoep, was named in the Intellectual Asset Management­ IAM Patent 1000 as one of the top patent specialists in the world. It is universally acknowledged as the definitive guide to leading patent lawyers, attorneys and firms in over 40 jurisdictions.

IAM’s recognition reads: “In operation since 2009, CreateIP is a refreshing option for clients and a firm that challenges conventional […]

June 8th, 2017|

Catapult Employment Services thanks CreateIP

For many people, Christmas is really hard. This is why we choose to thank our customers by donating, on their behalf, the money we would have spent on cards and gifts to support a charity that helps people truly in need of support.
Last Christmas, we donated to Catapult Employment Services who help people with disabilities and health conditions to find paid and ongoing employment. In the last 12 years, they have helped over 1200 people find employment, and were recognised at the 2016 Champion Canterbury Awards for their admirable work.

As finalist of the Champion Professional Service category of the same […]

March 17th, 2017|

CreateIP finalist in NZ Law Awards 2016

We’re delighted that, for the fourth year in a row, we have made the finals of the New Zealand Law Awards in the Intellectual Property Specialist Law Firm of the Year category.

The winners will be announced at the 12th annual New Zealand Law Awards on Thursday 17 November at The Langham hotel in Auckland.

We wish all the very best of luck to all the finalists.

September 19th, 2016|

Front page for Champion Canterbury finalist

Staff and friends of Create IP were pleasantly surprised to wake up to a familiar face on the front page of their Christchurch Press newspaper this morning.

CreateIP founder, Robert Snoep, was interviewed and videoed by the Press for achieving finalist position in the Champion Professional Service – Small Enterprise category of the 2016 Champion Canterbury Business Awards.

When asked what is the best way to protect and commercialise a new idea, Robert’s strongest recommendation is to not disclose the idea to others. “Breathe, collect information, do search work and figure out where you are at first,” he said.

A lot of inventors have great ideas, […]

September 5th, 2016|

Negotiating China’s new IP landscape

Rachel Colley of CreateIP shares four key strategies that a company wishing to access the China market can implement to best protect itself, and pre-empt IP issues.

 
2015 has seen the influence and importance of China continue to increase, and the case for having a presence in the Chinese market grows more compelling every day. Yet entry into China still scares a number of international companies. IP theft is perceived as being rife and doubts as to fair treatment in the country’s legal systems are some of the barriers to foreign companies.
 
However, China is on track to transition from a nation […]

February 23rd, 2016|

Law Awards 2015 Medal

CreateIP is delighted to announce that for the third year running, it is a finalist in the ‘Intellectual Property Specialist Law Firm Of The Year’ award at the 2015 New Zealand Law Awards. The winner will be announced at the awards ceremony taking place in Auckland on 17 November 2015. Fingers crossed and watch this space!

October 23rd, 2015|

D’Arcy v Myriad Genetics Inc & Anor

D’Arcy v Myriad Genetics Inc & Anor: Australian High Court rules that isolated genetic material is not patentable subject matter.

In a reversal of the previous decision of the Federal Court of Australia, the High Court of Australia (highest Australian court) ruled on 7 October 2015 that isolated genetic material coding for a polypeptide (in the form of DNA or RNA) is not patentable subject matter (http://www.hcourt.gov.au/cases/case_s28-2015).

The judgment held that an isolated nucleic acid coding for the BRCA1 protein with specific variations indicative of breast and ovarian cancer (as claimed in claims 1-3 of Australian Patent No. 686004) does not fall […]

October 23rd, 2015|